Uncomplicated skin infections account for almost 200 million physician-office visits in the USA annually. Treating these infections is estimated to cost in excess of US$350 million each year. The ...

retapamulin (Altabax; GlaxoSmithKline), a pleuromutilin approved in 2008; and tigecycline (Tygacil; Pfizer), a next-generation tetracycline approved in 2005. The reasons behind the decline in ...

Retapamulin(Altabax) generic is a pleuromutilin antibiotic, prescribed for impetigo. It works by killing and stopping the growth of bacteria on the skin. Note: Please check your Spam folder or ...

GSK subsequently used the molecular toolkit to help validate another antibiotic, Altargo/Altabax, which was approved for use in the EU in 2007. The toolkit has also enabled researchers to bolster the ...

A review of these studies noted the following: Efficacy of antibiotics over placebo for impetigo was demonstrated in two of three studies (using retapamulin [Altabax ®] and fusidic acid ...